Ballard Power Systems (NASDAQ:BLDP – Get Free Report) (TSE:BLD) had its price objective reduced by stock analysts at Susquehanna from $3.50 to $3.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “neutral” rating on the technology company’s stock. Susquehanna’s price objective indicates a potential upside of 15.16% from the company’s […]

Celsius (NASDAQ:CELH – Get Free Report) had its price objective reduced by equities researchers at Stephens from $65.00 to $50.00 in a research note issued on Monday, MarketBeat reports. The brokerage presently has an “overweight” rating on the stock. Stephens’ target price points to a potential upside of 80.05% from the stock’s current price. Several […]

Limbach (NASDAQ:LMB – Get Free Report) had its price objective reduced by Stifel Nicolaus from $107.00 to $86.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the construction company’s stock. Stifel Nicolaus’ target price indicates a potential upside of 76.59% from the stock’s current price. Several other research […]

AbCellera Biologics (NASDAQ:ABCL – Get Free Report) had its price target increased by investment analysts at Stifel Nicolaus from $8.00 to $9.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective points to a potential upside of 44.76% from the stock’s previous […]

Illumina (NASDAQ:ILMN – Free Report) had its target price increased by Stifel Nicolaus from $155.00 to $225.00 in a report published on Friday morning,Benzinga reports. They currently have a buy rating on the life sciences company’s stock. A number of other research firms also recently weighed in on ILMN. Leerink Partners raised their price target […]

IQVIA (NYSE:IQV – Get Free Report) had its price objective increased by Stifel Nicolaus from $220.00 to $276.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the medical research company’s stock. Stifel Nicolaus’ price objective would indicate a potential upside of 12.00% from the stock’s […]